A website from the team of Medical Pharmacology of Tours University Hospital and Tours University, France

Links to main pages

• Our publications

• French Reference Medical Biology Laboratory (Laboratoire de Biologie Médicale de Référence, LBMR) for the therapeutic drug monitoring of monoclonal antibodies

- Patient care: Please ask Dr David Ternant (david.ternant@univ-tours.fr) for the prescription form in English.

- Biomedical research: Consult the page of Pilot centre for Therapeutic Antibodies Monitoring (Centre Pilote de suivi Biologique des traitements par Anticorps, CePiBAc) (in French)

- More information on the Reference Medical Biology Laboratory (LBMR) for therapeutic drug monitoring of monoclonal antibodies

- More information on the other Reference Medical Biology Laboratories (in French)

Our structures

• Medical Pharmacology, Tours University Hospital: Twitter

• Pilot centre for Therapeutic Antibodies Monitoring (Centre Pilote de suivi Biologique des traitements par Anticorps, CePiBAc), a unit of the Research Platform of Tours University Hospital

• Faculty of Medicine, University of Tours

• Equipe Inserm UMR1327 ISCHEMIA, University of Tours: Twitter

Our networks

• Tours - Montpellier

LabEx MabImprove, Laboratory of Excellence for “improved antibodies, improved development and improved use”

• West Region

MIAMIGO, network of investigators of the interregional group of clinical research and innovation (Groupement Interrégional de Recherche Clinique et d'Innovation - GIRCI - Grand Ouest (with link to pages in English)

• France

French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et de Thérapeutique, SFPT), and Therapeutic Drug Monitoring working group

• Europe

Biopia (Biopharmaceutical Pharmacokinetic and Immunogenicity Assessment)

Action COST ENOTTA

Contacts

• email: cepibac@chu-tours.fr

• Team - e-mails (in French)

• Secretariat: 02 47 47 60 08 - secretariat-phto@chu-tours.fr

 Webmaster : gilles.paintaud@univ-tours.fr

Keywords: antibodies monoclonal antibodies pharmacology pharmacokinetics CePiBAc adalimumab Humira basiliximab Simulect bevacizumab Avastin cetuximab Erbitux eculizumab Soliris etanercept Enbrel infliximab Remicade nivolumab Opdivo panitumumab Vectibix pembrolizumab Keytruda ramucirumab Cyramza rituximab Mabthera tocilizumab Roactemra trastuzumab Herceptin Tours LBMR laboratoire biologie médicale référence PK-PD LBM

Updated: July 24th, 2024